Developing Novel Host-Based Therapies Targeting Microbicidal Responses in Macrophages and Neutrophils to Combat Bacterial Antimicrobial Resistance
Open Access
- 5 June 2020
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 11, 786
- https://doi.org/10.3389/fimmu.2020.00786
Abstract
Antimicrobial therapy has provided the main component of chemotherapy against bacterial pathogens. The effectiveness of this strategy has, however, been increasingly challenged by the emergence of antimicrobial resistance which now threatens the sustained utility of this approach. Humans and animals are constantly exposed to bacteria and have developed effective strategies to control pathogens involving innate and adaptive immune responses. Impaired pathogen handling by the innate immune system is a key determinant of susceptibility to bacterial infection. However, the essential components of this response, specifically those which are amenable to re-calibration to improve host defense, remain elusive despite extensive research. We provide a mini-review focusing on therapeutic targeting of microbicidal responses in macrophages and neutrophils to de-stress reliance on antimicrobial therapy. We highlight pre-clinical and clinical data pointing toward potential targets and therapies. We suggest that developing focused host-directed therapeutic strategies to enhance “pauci-inflammatory” microbial killing in myeloid phagocytes that maximizes pathogen clearance while minimizing the harmful consequences of the inflammatory response merits particular attention. We also suggest the importance of One Health approaches in developing host-based approaches through model development and comparative medicine in informing our understanding of how to deliver this strategy.Funding Information
- Medical Research Council
This publication has 94 references indexed in Scilit:
- TLR signalling augments macrophage bactericidal activity through mitochondrial ROSNature, 2011
- A Cardinal Role for Cathepsin D in Co-Ordinating the Host-Mediated Apoptosis of Macrophages and Killing of PneumococciPLoS Pathogens, 2011
- Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysisCritical Care, 2011
- Statins Enhance Formation of Phagocyte Extracellular TrapsCell Host & Microbe, 2010
- Innate immunityJournal of Allergy and Clinical Immunology, 2010
- Statins protect against fulminant pneumococcal infection and cytolysin toxicity in a mouse model of sickle cell diseaseJCI Insight, 2010
- Macrophage elastase kills bacteria within murine macrophagesNature, 2009
- The Compensatory Anti-inflammatory Response Syndrome (CARS) in Critically Ill PatientsClinics in Chest Medicine, 2008
- Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort studyBMJ, 2006
- Neutrophil Extracellular Traps Kill BacteriaScience, 2004